RNASE1 and cancer: Furthermore, the cancer cell membrane (CM) was coated with the RNase-A-loaded diselenide-bridged MSNs to construct a bioinspired nanoplatform MSN@RNase A@CM, displaying homologous targeting and immune-evading properties.